Results 151 to 160 of about 425,993 (391)

Seroprevalence and Associated Factors of Hepatitis B and Hepatitis C Viral Infections Among Prisoners in Tigrai, Northern Ethiopia

Infection and Drug Resistance, 2023
Belaynesh Tsegay,1 Teklay Gebrecherkos,2 Atsebaha Gebrekidan Kahsay,2 Mahmud Abdulkader2 1Ayder Comprehensive Specialized Hospital Laboratory Department, Mekelle University, Mekelle, Tigrai, Northern Ethiopia; 2Department of Medical Microbiology and ...
Tsegay B, Gebrecherkos T, Kahsay AG, Abdulkader M   +3 more
doaj  

Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: Correlation with disease activity and response to interferon-α [PDF]

, 1994
H Löhr, Christopher Nagel, Hans‐Peter Dienes, B Simpson, Gerd Michel, Bernd Goergen, Karl‐Hermann Meyer zum Büschenfelde, Guido Gerken   +7 more
openalex   +1 more source

Threshold value of the anti-HCV test in the diagnosis of HCV infection

The Journal of Infection in Developing Countries, 2019
Introduction: In the diagnosis of hepatitis C virus (HCV) infection, the first step is screening for anti-HCV antibodies, and positive results are generally confirmed with nucleic acid amplification tests. Recent studies have reported that more compatible results have been obtained with the HCV RNA test using signal to cut-off (S/Co) values >1 ...
Kirişci Ö, Çalışkan, Ahmet
openaire   +8 more sources

Hepatitis C virus (HCV)-specific in vitro antibody secretion by peripheral blood lymphocytes: correlation with progression of disease and HCV RNA in HCV antibody-positive patients [PDF]

, 1994
J Ducos, A-M Bianchi-Mondain, Marie François, Michel Boisset, J.-P. Vendrell, Françis Barin, A Serre, Dominique Larrey   +7 more
openalex   +1 more source

Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection

Hepatology, 2014
All‐oral combinations of direct‐acting antivirals may improve efficacy and safety outcomes for patients with hepatitis C virus (HCV) infection, particularly those who are poor candidates for current interferon/ribavirin‐based regimens. In this open‐label,
H. Kumada, Yoshiyuki Suzuki, K. Ikeda, J. Toyota, Y. Karino, K. Chayama, Y. Kawakami, A. Ido, Kazuhide Yamamoto, K. Takaguchi, N. Izumi, K. Koike, T. Takehara, N. Kawada, M. Sata, H. Miyagoshi, T. Eley, F. Mcphee, A. Damokosh, H. Ishikawa, E. Hughes   +20 more
semanticscholar   +1 more source

Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results. [PDF]

, 1993
Gordon S. Baskin, Robert K. DiNello, A. Polito, S. Quan, W S Lee, Jia‐Feng Wu, M J Nelles, S Lee   +7 more
openalex   +1 more source

Impact Of Hepatitis C Co-Infection On CD4 Cell Count In HIV Infected Subjects [PDF]

, 2008
Background: Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) co-infection is reported to be common among HIV infected subjects due to share routes of transmission.
Emokpae, MA, Jegede, EE, Nwokedi, EE
core  

The Fibrosis‐4 score is associated with overall mortality and severe haematological toxicity in older patients with cancer: Analysis of two prospective cohort studies

International Journal of Cancer, EarlyView.
What's New? Liver function decreases with age, affecting the metabolism of many chemotherapy drugs. For older cancer patients, however, a standardized liver status screening method is lacking. Here, Fibrosis‐4 (FIB‐4) score was investigated for its utility as a non‐invasive method in predicting treatment toxicity and mortality in cancer patients age 70
Victoire de Salins, Claudia Martinez‐Tapia, Pierre Gay, Antoine Morel, Michael Bringuier, Pascaline Boudou‐Rouquette, Lola Corsin, Amélie Aregui, Johanna Canovas, Pierre‐Emmanuel Rautou, Pierre Soubeyran, Carine Bellera, Florence Canoui‐Poitrine, Elena Paillaud, Johanne Poisson   +14 more
wiley   +1 more source

Hepatites pós-transfusionais na cidade de Campinas, SP, Brasil: II. Presença dos anticorpos anti-HBc e anti-HCV em candidatos a doadores de sangue e ocorrência de hepatites pós-transfusionais pelo vírus C nos receptores de sangue ou derivados [PDF]

, 1993
Fernando Lopes Gonçales Júnior, Rogério de Jesus Pedro, Luiz Jacintho da Silva, Raquel Silveira Bello Stucchi Boccato, Neiva Sellan Lopes Gonçales   +4 more
openalex   +1 more source

Genetic variants underlying precancerous conditions of hepatocellular carcinoma

International Journal of Cancer, EarlyView.
Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for 80% of cases worldwide. While chronic hepatitis B and C infections remain primary risk factors, emerging evidence highlights the increasing contributions of metabolic dysfunction‐associated steatotic liver disease (MASLD) and alcohol‐associated liver disease
Jonathan Jaime G. Guerrero, Paolo C. Encarnacion, Mark Angelo S. del Rosario, Matthew Aldren S. Ora, Jiayan Zhou, Kin Israel Notarte, Wan‐Chun Li, Ching‐Wen Chang   +7 more
wiley   +1 more source